by admin | May 16, 2023 | News & Opinions
by John Cumbers – Forbes After being at the helm for over a decade of internet juggernaut Google GOOG -0.8%, former CEO Eric Schmidt has switched gears and one of his latest activities is being an advocate for the fast-growing US bioeconomy, which is valued at...
by admin | May 15, 2023 | News & Opinions
by Innovation Quarter From developing the world’s first lab-grown organ (a bladder) to the body-on-a-chip platform used for drug toxicity testing and personalized medicine, Winston-Salem-based scientists have been integral to cutting-edge regenerative medicine...
by admin | May 15, 2023 | News & Opinions
By Michael Irving – News Atlas Scientists in Canada have developed a new technique that may one day help restore some sight to patients with inherited vision impairment. The regenerative therapy works by expressing genes that convert dormant cells into new...
by admin | May 14, 2023 | News & Opinions
Intrathecal mesenchymal stem cell-neural progenitor therapy failed to significantly improve the EDSS or the EDSS Plus versus placebo in progressive MS. by Physician’s Weekly Mesenchymal stem cell-neural progenitor therapy (MSC-NPs) are bone marrow-derived cells...
by admin | May 13, 2023 | News & Opinions
STING-seq provides roadmap to identify variants and genes, enabling deeper understanding of the noncoding genome and targets for therapies By NYU News A major challenge in human genetics is understanding which parts of the genome drive specific traits or contribute to...